Advanced Head And Neck Squamous Cell Carcinoma clinical trials

Explore recruiting advanced head and neck squamous cell carcinoma clinical trials.

Recruiting advanced head and neck squamous cell carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Head And Neck Squamous Cell Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

BelieveIT-201: A Randomized, Phase 2, Open-label Trial of TransCon TLR7/8 Agonist in Combination with Pembrolizumab, TransCon TLR7/8 Agonist in Combination with TransCon IL-2 β/γ, or Pembrolizumab Monotherapy as Neoadjuvant Therapy in Participants with Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)

Spain, Hungary, Poland, Germany, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A PHASE 2 STUDY OF ALX148 IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (ASPEN-03)

Netherlands, Belgium, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase III, Randomized, Open-label Study to Evaluate Pembrolizumab as Neoadjuvant Therapy and in Combination With Standard of Care as Adjuvant Therapy for Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA HNSCC)

Ireland, Portugal, Germany, Belgium, Hungary, Austria +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A PHASE 2 STUDY OF ALX148 IN COMBINATION WITH PEMBROLIZUMAB AND CHEMOTHERAPY IN PATIENTS WITH ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (ASPEN-04)

Belgium, Netherlands, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase Ib/II non-randomized non-comparative two-cohort study of Niraparib and Dostarlimab plus (Chemo)RadIotherapy in Locally-Advanced head and Neck squamous cell carcinoma (RADIAN)

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

EORTC 2120-HNCG: Radiotherapy plus xevinapant or placebo in older patients with locally advanced head and neck squamous cell carcinoma: a randomized phase II study (Ravina)

Italy, Slovenia, Germany, Netherlands, Belgium, Norway +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Advanced Head And Neck Squamous Cell Carcinoma trials by city

Advanced Head And Neck Squamous Cell Carcinoma in Toronto Advanced Head And Neck Squamous Cell Carcinoma in Vancouver Advanced Head And Neck Squamous Cell Carcinoma in Montreal Advanced Head And Neck Squamous Cell Carcinoma in Calgary Advanced Head And Neck Squamous Cell Carcinoma in Edmonton Advanced Head And Neck Squamous Cell Carcinoma in Ottawa Advanced Head And Neck Squamous Cell Carcinoma in Winnipeg Advanced Head And Neck Squamous Cell Carcinoma in Quebec City Advanced Head And Neck Squamous Cell Carcinoma in Hamilton Advanced Head And Neck Squamous Cell Carcinoma in Kitchener Advanced Head And Neck Squamous Cell Carcinoma in London Advanced Head And Neck Squamous Cell Carcinoma in Halifax Advanced Head And Neck Squamous Cell Carcinoma in New York Advanced Head And Neck Squamous Cell Carcinoma in Los Angeles Advanced Head And Neck Squamous Cell Carcinoma in Chicago Advanced Head And Neck Squamous Cell Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease